Abstract Pharmaceutical formulations for once daily oral administration comprising Ibrutinib or a pharmaceutically acceptable salt or solvate or hydrate thereof, and surfactant optionally contains one or more pharmaceutically acceptable excipients. Methods for preparing such formulations and their use in the treatment of diseases for which Ibrutinib is indicated.